| __timestamp | Sarepta Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 24518692 |
| Thursday, January 1, 2015 | 75043000 | 19886580 |
| Friday, January 1, 2016 | 83749000 | 12631689 |
| Sunday, January 1, 2017 | 122682000 | 21977998 |
| Monday, January 1, 2018 | 207761000 | 20759000 |
| Tuesday, January 1, 2019 | 284812000 | 20838000 |
| Wednesday, January 1, 2020 | 317875000 | 121812000 |
| Friday, January 1, 2021 | 282660000 | 152137000 |
| Saturday, January 1, 2022 | 451421000 | 83231000 |
| Sunday, January 1, 2023 | 481871000 | 122706000 |
Data in motion
In the competitive world of biotechnology, managing expenses is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and TG Therapeutics, Inc. from 2014 to 2023. Over this period, Sarepta's SG&A expenses surged by over 870%, peaking in 2023, reflecting its aggressive expansion and marketing strategies. In contrast, TG Therapeutics experienced a more modest increase of approximately 400%, with a significant spike in 2020 and 2021, likely due to strategic investments in commercialization efforts. This divergence highlights the different growth trajectories and strategic priorities of these two companies. Understanding these trends provides valuable insights into how biotech firms allocate resources to drive innovation and market presence.
Comparing SG&A Expenses: Bristol-Myers Squibb Company vs Sarepta Therapeutics, Inc. Trends and Insights
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs ADMA Biologics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Sarepta Therapeutics, Inc. and CRISPR Therapeutics AG
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Sarepta Therapeutics, Inc. and MiMedx Group, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Vericel Corporation Trends and Insights
Breaking Down SG&A Expenses: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: TG Therapeutics, Inc. vs ImmunityBio, Inc. Trends and Insights